Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus (Q40687703)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 2002

Language	Label	Description	Also known as
English	Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus	scientific article published on December 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

vector-borne disease

0 references

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Oscar Bruna-Romero

7

0 references

Juan José Lasarte

12

0 references

Gláucia Paranhos-Baccalà

9

object named as

Glaucia Paranhos-Baccala

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

4

object named as

Noelia Casares

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Francisco Borrás-Cuesta

8

object named as

Francisco Borrás-Cuesta

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Laura Arribillaga

1

object named as

Laura Arribillaga

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

5

object named as

Marta Gorraiz

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Ascensión López-Díaz de Cerio

2

object named as

Ascensión López Díaz de Cerio

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

author name string

Africa Vales

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Juan Ruiz

11

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

language of work or name

0 references

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

3-4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

202-210

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Randomised trial of lymphoblastoid alpha-interferon in chronic hepatitis C. Effects on inflammation, fibrogenesis and viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

T-lymphocyte response to hepatitis C virus in different clinical courses of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of a successful immune response against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants of viral clearance and persistence during acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of HIV-1 proteins in Escherichia coli by a modified expression vector and their one-step purification.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Insights on the amino acid side-chain interactions of a synthetic T-cell determinant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Peptides naturally presented by MHC class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

H-2Dd exploits a four residue peptide binding motif

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of the specific T-cell response for clearance and control of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-1-restricted CTL response and protection in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune response in mice that lack the interferon-gamma receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral mutations, TCR antagonism and escape from the immune response.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of patients with chronic hepatitis C treated with α-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900456-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(02)00456-5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40687703&oldid=2047637954"